Andrew Callos - 14 Mar 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: EVP, Chief Commercial Officer
Signature: /s/ John Faurescu, attorney-in-fact for Mr. Callos
Issuer symbol: CYTK
Transactions as of: 14 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 18 Mar 2024, 19:02:42 UTC
Previous filing: 07 Mar 2024
Next filing: 05 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Award	$0	+16,941	+36%	$0.000000	63,887	14 Mar 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Award	$0	+18,346		$0.000000	18,346	14 Mar 2024	Common Stock	18,346	$63.75	Direct	F2
transaction	CYTK	Incentive Stock Option (Right to Buy)	Award	$0	+1,224		$0.000000	1,224	14 Mar 2024	Common Stock	1,224	$63.75	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
F2	This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028.